CDLX Form 144: Insider to sell 6,098 shares acquired on 10/01/2025

Rhea-AI Filing Summary

Cardlytics, Inc. (CDLX) filed a Form 144 reporting a proposed sale of 6,098 common shares acquired on 10/01/2025 via restricted stock vesting. The filing lists an aggregate market value of $13,847.95 and an approximate sale date of 10/02/2025 on NASDAQ. The filer previously sold 5,271 shares on 07/02/2025 for $9,396.09. The form includes the standard representation that the seller does not possess undisclosed material information about the issuer.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	6098	13847.95	53236901	10/02/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/01/2025	Restricted Stock Vesting	Issuer			6098	10/01/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Nicholas H. Lynton 675 Ponce de Leon Ave. NE Suite 4100 Atlanta GA 30308	Common	07/02/2025	5271	9396.09

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Cardlytics (CDLX) Form 144 report?

The filing reports a proposed sale of 6,098 common shares acquired by restricted stock vesting on 10/01/2025, with an approximate sale date of 10/02/2025.

How much are the shares reported in the CDLX Form 144 worth?

The filing lists an aggregate market value of $13,847.95 for the 6,098 shares to be sold.

Who sold shares previously and what were the proceeds?

The filing shows Nicholas H. Lynton sold 5,271 shares on 07/02/2025 for $9,396.09.

What type of acquisition produced the shares being sold in the Form 144?

The securities were acquired through restricted stock vesting and the reported nature of payment is compensation.

Does the filer state they possess undisclosed material information?

No; the filer represents by signature that they do not know any material adverse information about the issuer that has not been publicly disclosed.